2020
DOI: 10.3389/fonc.2020.00183
|View full text |Cite
|
Sign up to set email alerts
|

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma

Abstract: Background: Epithelial-mesenchymal transition (EMT) is regulated by induction factors, transcription factor families and an array of signaling pathways genes, and has been implicated in the invasion and progression of gliomas. Methods: We obtained the Clinicopathological data sets from Chinese Glioma Genome Atlas (CGGA). The "limma" package was used to analyze the expression of EMT-related genes in gliomas with different pathological characteristics. We used the "ConsensusClusterPlus" package to divide gliomas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
56
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
3
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 64 publications
(58 citation statements)
references
References 50 publications
2
56
0
Order By: Relevance
“…Various markers and gene signatures of the EMT and their association with the tumor microenvironment are currently being evaluated for prognosis prediction (92), for example in head and neck squamous cell carcinoma (93) and glioma (94). Although further research is needed to confirm the use of EMT markers or signatures as predictors of cancer prognosis, this is a promising development for the field.…”
Section: The Heterogeneity Of the Endometriummentioning
confidence: 99%
“…Various markers and gene signatures of the EMT and their association with the tumor microenvironment are currently being evaluated for prognosis prediction (92), for example in head and neck squamous cell carcinoma (93) and glioma (94). Although further research is needed to confirm the use of EMT markers or signatures as predictors of cancer prognosis, this is a promising development for the field.…”
Section: The Heterogeneity Of the Endometriummentioning
confidence: 99%
“…It has been reported that clinical characteristics, such as age, stage, differentiation and lymph node metastasis, cannot accurately predict the prognosis of patients [23]. As a result, an increasing number of studies are exploring gene biomarkers, and many studies have found that developing multiple generelated risk models can improve the prediction e ciency [24,25]. Therefore, the purpose of this study was to explore the risk biomarkers related to the prognosis of endometrial cancer and to analyze further their relationship with immune cell in ltration.…”
Section: Discussionmentioning
confidence: 99%
“…The m6A-related prognostic lncRNAs screened from the two databases are intersected to obtain the 24 shared m6A-related prognostic lncRNAs. Thereafter, using the R package “glmnet” ( Friedman et al, 2010 ) to conduct least absolute shrinkage and selection operator (LASSO) Cox regression (with the penalty parameter estimated by 10-fold cross-validation) ( Tao et al, 2020 ), we developed a m6A-related lncRNA prognostic signature (m6A-LPS) for the LGG patients involving 9 m6A-related lncRNAs. The risk score calculating formula is:…”
Section: Methodsmentioning
confidence: 99%